Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Integrity BioChem is a private specialty chemicals company focused on bio-based surfactant chemistry and modified biopolymers rather than therapeutics or medical products. Founded in 2017 and based in Cresson, Texas, the company develops and manufactures sustainable, plant-derived chemical solutions for markets including energy, mining, agriculture, industrial applications, and household and personal care. Its products are positioned as high-performance alternatives to conventional synthetic surfactants, with an emphasis on scalability, zero-waste manufacturing, and global supply reliability. The company appears to be commercially operating, with an established manufacturing site and a leadership team led by founder and CEO Jimmy Jett. Although it is sometimes surfaced in life-science-adjacent databases because of its biochemistry focus, it is best classified as an industrial bio-based chemicals company, not a biotech or pharmaceutical developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Integrity BioChem.